Life Sciences: An Undervalued Megatrend?

🧬 Invest in top-performing biotech stocks Install FREE app : optothemes.onelink.me/BZDG/ti...
Over the past 25 years, the Nasdaq Biotechnology Index has outperformed the S&P500 by 467%.
This growth, fueled by a tripling in FDA drug approvals since 2002, coincides with the UN's prediction that the over-60 population will double by 2050, driving healthcare spending to unprecedented levels.
Today, we delve into the challenges and opportunities in the biotech sector with Yuri Khodjamirian, CIO of Tema ETFs. We explore how investors can navigate the sector's regulatory, scientific, and funding risks to capitalise on this demographic shift and historically low valuations.
Prior to Tema ETFs, Yuri spent over a decade at Majedie Asset Management managing the firm’s UK and global portfolios. Enjoy!
🎯 Key Takeaways:
00:00 Start
01:37 Life Sciences Growth
05:46 Personalised Medicine
06:32 How US Elections Outcome Could Impact Biotech
8:49 AI's Impact on Biotech
15:40 Managing Risks in Biotech Investments
20:08 Ethical Considerations
26:14 How to Invest in Biotech
31:40 Tema's Investment Process
34:21 Funds Strategy & Performance
40:21 Innovative Cancer Treatments: ADCs & Radiotherapy
📲 Invest in innovation with OPTO Install FREE app : optothemes.onelink.me/BZDG/ti...
X: / optothemes
Instagram: opto.themes...
LinkedIn: / opto-invest-in-innovat...
Facebook: / optothemes
#biotech #lifesciences #biotechstocks #biotechnology #investininnovation #temaetfs
Disclaimer: optothemes.com/disclosures-an...

[@OptoThemes]

🧬 *Find top-performing biotech stocks* _Invest with OPTO_ : optothemes.onelink.me/BZDG/ti2lb2fd

[@AsherCore]

😊n